Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Another Biosimilar Legislative Defeat For Amgen & Genentech
Pharmalot
Tuesday, May 7, 2013 - 11:43am
tags:
biosimilars, Amgen, Genentech
Alnylam takes smaller 1Q loss on lower costs
Yahoo/AP
Tuesday, May 7, 2013 - 11:41am
tags:
Alnylam, earnings
Leading Biotechs Act Well But Be Careful Not To Chase
Investors.com
Tuesday, May 7, 2013 - 11:39am
tags:
Biogen Idec, Regeneron, Amgen, Celgene, Gilead
Jazz Pharmaceuticals Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Tuesday, May 7, 2013 - 11:33am
tags:
Jazz Pharmaceuticals, earnings
Small Companies Are Leading Innovation For New Drugs To Treat Depression
Forbes
Tuesday, May 7, 2013 - 11:31am
tags:
clinical depression, Lundbeck, Alkermes, Novartis, Pfizer, AstraZeneca, Merck, Sanofi
Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment
Forbes
Tuesday, May 7, 2013 - 11:07am
tags:
Alzheimer's disease, Baxter International, Gammagard
Endo Health turns 1Q profit, affirms 2013 forecast
Yahoo/AP
Tuesday, May 7, 2013 - 11:04am
tags:
earnings, Endo Health Solutions
Regeneron: Solid Q1 Creates Platform For Further Upside
Seeking Alpha
Tuesday, May 7, 2013 - 11:00am
tags:
Regeneron, earnings
Merck: A Negative Growth Story
Seeking Alpha
Tuesday, May 7, 2013 - 10:57am
tags:
Merck
FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
Marketwatch
Monday, May 6, 2013 - 11:34am
tags:
FDA, breakthrough therapies, hepatitis C, AbbVie
Medtronic receives FDA approval for newest cardiac devices
Yahoo/Fly on the Wall
Monday, May 6, 2013 - 11:24am
tags:
FDA, Medtronic, devices, Evera, Viva
NeuroPhage banks $6.4M for Alzheimer's drug development effort
Fierce Biotech
Monday, May 6, 2013 - 11:21am
tags:
NeuroPhage, Alzheimer's disease, NPT002
Merck wins FDA nod for new Zetia-Lipitor combo, despite lack of outcomes benefit
Fierce Pharma
Monday, May 6, 2013 - 11:19am
tags:
FDA, Merck, Zetia, Lipitor, Liptruzet
Big Pharma Disappoints on Revenues, Earnings
CNBC
Monday, May 6, 2013 - 11:17am
tags:
earnings, Big Pharma
Cadence Pharmaceuticals: Ofirmev Launch Is Strong; Resolution Of Patent Issues Could Be Soon
Seeking Alpha
Monday, May 6, 2013 - 10:52am
tags:
Cadence Pharmaceuticals, Ofirmev
2013 Will be a Banner Year for GeoVax
Yahoo/Zacks
Monday, May 6, 2013 - 10:51am
tags:
GeoVax, earnings
FDA Will Find Docs Still Detest DTC Advertising: Survey
Pharmalot
Monday, May 6, 2013 - 10:49am
tags:
FDA, DTC, physicians
Netupitant Results Could Roil Tesaro In May
Seeking Alpha
Monday, May 6, 2013 - 10:48am
tags:
Tesaro, Netupitant, breast cancer, ovarian cancer, niraparib, Sanofi, Roche, OPKO Health, Merck, GSK, Eisai
Pfizer to start selling Viagra online
CNN Money
Monday, May 6, 2013 - 10:43am
tags:
Pfizer, Viagra
Cost Cutting Initiative to Bolster GlaxoSmithKline's Earnings
Motley Fool
Monday, May 6, 2013 - 10:23am
tags:
earnings, GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.